Download table 1 2011 pharmaceutical market performance by

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

page
1
page
2
page
3
page
4
Document related concepts
no text concepts found
Transcript 
TABLE 1
2011 PHARMACEUTICAL MARKET PERFORMANCE
BY SEGMENT
Market Segment
% Growth
2011 over 2010
Total Market
-1.0
Brand Market*
0.5
Biotechnology**
12.5
Oncology
2.4
Generics Market
-5.3
Source: IMS Brogan, Canadian Drug Store and Hospital Purchases, MAT December 2011.
Estimated value of ethical products purchased by retail pharmacies and hospitals at invoice
price.
* The Brand Market segment definition includes the Biotech and Oncology segments.
Numbers are NOT mutually exclusive and will not add to 100%.
**Biotechnology market segment includes certain Oncology products.
1 TABLE 2
BRAND vs. GENERIC PRESCRIPTIONS DISPENSED, 2011†
Canada and by province
Brand (%)
Generic (%)
39.7
60.3
QUEBEC
41.6
58.4
ONTARIO
39.1
60.9
ALBERTA
37.9
62.1
SASKATCHEWAN
38.2
61.8
NOVA SCOTIA
39.7
60.3
NEW BRUNSWICK
37.0
63.0
MANITOBA
35.5
64.5
BRITISH
COLUMBIA
37.2
62.8
PEI
40.1
59.9
NFLD/LABRADOR
38.2
61.8
CANADA
Source: IMS Brogan, Canadian CompuScript
†
Percentage of prescriptions dispensed through retail pharmacies. Includes new and refills.
2 TABLE 3
PRESCRIPTIONS DISPENSED IN RETAIL PHARMACIES
PER CAPITA, BY PROVINCE†‡, 2011
2011
Retail spending
per capita*
($)
CANADA
QUEBEC‡
NEW BRUNSWICK
NFLD/LABRADOR
NOVA SCOTIA
2011
Prescriptions
per capita
690
16
850
27
855
14
835
15
816
13
PEI
ONTARIO
702
12
665
13
SASKATCHEWAN
621
13
MANITOBA
604
12
ALBERTA
610
10
BRITISH COLUMBIA
533
10
Source: IMS Brogan, Canadian CompuScript Audit, and Statistics Canada
†
Population numbers based on Statistics Canada population estimates dated September 29, 2010.
Prescriptions in Quebec are normally of a shorter duration than all other provinces; therefore, the
number of retail prescriptions dispensed is higher.
*
Includes cost of drugs plus any mark-ups and pharmacists’ professional fees. Excludes hospitals.
‡
3 TABLE 4
TOP 10 PHARMACEUTICAL CORPORATIONS IN CANADA,
2011
Purchases by
pharmacies
and hospitals†
Rank
2011
Corporation1
($ billion)
% Change
over 2010
1
Johnson & Johnson
1.75
6.6
2
AstraZeneca
1.68
3.0
3
Pfizer
1.57
-25.5
4
Teva Canada
1.21
-24.1
5
Apotex
1.21
-10.7
6
Merck Canada Inc
1.11
6.2
7
Novartis
0.98
1.9
8
GlaxoSmithKline
0.93
-4.2
9
Abbott
0.88
4.7
10
Roche
0.73
5.0
Source: IMS Brogan, Canadian Drugstore & Hospital Purchases Audit
1
Corporations include all divisions or subsidiaries that manufacture pharmaceutical products.
Invoice price. All dollar figures in Canadian funds. Does not include purchases made by Canadian
internet pharmacies for sale to U.S. customers.
†
4
Related documents